Granulocyte-macrophage-colony stimulating factor in metastatic renal cell carcinoma

This publication has 17 references indexed in Scilit:

• Cancer statistics, 1997
  CA: A Cancer Journal for Clinicians, 1997
• Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinoma
  Cancer, 1996
• Proliferating dendritic cell progenitors in human blood.
  The Journal of Experimental Medicine, 1994
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
  Proceedings of the National Academy of Sciences, 1993
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
  The Journal of Experimental Medicine, 1992
• Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality
  Life Sciences, 1989
• Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils.
  Proceedings of the National Academy of Sciences, 1988
• Production of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte- macrophage colony-stimulating factor [see comments]
  Blood, 1988
• The Human Hematopoietic Colony-Stimulating Factors
  Science, 1987
• Hematopoietic growth factors.
  Journal of Clinical Investigation, 1987